SCHEMBL363904

SCHEMBL363904

COCOc1cccc(N)c1Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
ADRA2B P18089 1/20 0.41
PTGS1 P23219 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CYP2C19 P33261 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
PTPN1 P18031 1/20 0.37
NSD2 O96028 1/20 0.34
CASP6 P55212 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
CYP3A4 P08684 2/20 0.32
TSHR P16473 2/20 0.32
PIK3CA P42336 2/20 0.32
ABL1 P00519 2/20 0.32
KDR P35968 2/20 0.32
CHEK1 O14757 1/20 0.32
AURKA O14965 1/20 0.32
DAPK3 O43293 1/20 0.32
JAK2 O60674 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16507220 0.86 PTPN1 (0.42) CYP2C19CYP1A2PTPN1SMN1; SMN2CYP3A4
SCHEMBL27926958 0.81 ALDH1A1 (0.64) ALDH1A1ADRA2BPTGS1TDP1CYP2C19
SCHEMBL9082172 0.81 PTPN1 (0.39) ALDH1A1TDP1CYP2C19CYP1A2CYP2C9
SCHEMBL11204587 0.80 ALDH1A1 (0.63) ALDH1A1ADRA2BPTGS1TDP1CYP2C19
SCHEMBL29493419 0.79 PTPN1 (0.49) ALDH1A1TDP1CYP2C19CYP1A2PTPN1
SCHEMBL19617278 0.79 PTPN1 (0.49) ALDH1A1TDP1CYP2C19CYP1A2PTPN1
SCHEMBL28111956 0.79 TSHR (0.48) ALDH1A1ADRA2BPTGS1TDP1CYP2C19
SCHEMBL562014 0.78 ALDH1A1 (0.60) ALDH1A1ADRA2BPTGS1TDP1NSD2
SCHEMBL29617909 0.78 PTPN1 (0.42) ALDH1A1ADRA2BPTGS1TDP1CYP2C19
SCHEMBL24596979 0.78 ALDH1A1 (0.41) ALDH1A1ADRA2BPTGS1TDP1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9382253-B2 Metal complexes MERCK PATENT GMBH (DE) 2016-07-05 US disclosed
US-9382253-B2 Metal complexes MERCK PATENT GMBH (DE) 2016-07-05 US disclosed
US-9382253-B2 Metal complexes MERCK PATENT GMBH (DE) 2016-07-05 US disclosed
US-20130112921-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-05-09 US disclosed
US-20130112921-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-05-09 US disclosed
US-20130112921-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-05-09 US disclosed
WO-2012007087-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130112921-A1 METAL COMPLEXES MCOLN2, MCOLN1, NCLN ALDH1A1 3236/4885ADRA2B 4650/4885PTGS1 2940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.